Lv11
70 积分 2025-08-26 加入
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
7天前
已完结
The role of interleukin-2 during homeostasis and activation of the immune system
21天前
已完结
Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy
21天前
已完结
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
22天前
已完结
Budesonide–glycopyrronium–formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials
23天前
已完结
IL-33, inflammation and mucus in COPD: the final FRONTIER?
1个月前
已完结
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials
2个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
5个月前
已完结
Adjuvant Immunotherapy in Lung Cancer
8个月前
已关闭
Towards a personalized utilization of stereotactic body radiotherapy for the management of liver metastases in solid tumors
8个月前
已完结
皖公网安备34019202002308
